I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl ki..:
Nam, Hyun-Jin
;
Im, Seock-Ah
;
Oh, Do-Youn
...
Molecular Cancer Therapeutics, Vol.12 No.1, pp.16-26. , 2020
Link:
https://hdl.handle.net/10371/173256
RT Journal T1
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_173256&Exemplar=1&LAN=DE A1 Nam, Hyun-Jin A1 Im, Seock-Ah A1 Oh, Do-Youn A1 Elvin, Paul A1 Kim, Hwang-Phill A1 Yoon, Young-Kwang A1 Min, Ahrum A1 Song, Sang-Hyun A1 Han, Sae-Won A1 Kim, Tae-You A1 Bang, Yung-Jue PB American Association for Cancer Research YR 2020 K1 GROWTH-FACTOR RECEPTOR K1 SRC FAMILY KINASES K1 BREAST-CANCER K1 CELL-LINES K1 CARCINOMA CELLS K1 TARGETING SRC K1 IN-VITRO K1 DASATINIB K1 ACTIVATION K1 TRASTUZUMAB JF Molecular Cancer Therapeutics, Vol.12 No.1, pp.16-26 LK http://dx.doi.org/https://hdl.handle.net/10371/173256 DO https://hdl.handle.net/10371/173256 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)